glycine has been researched along with Supranuclear Palsy, Progressive in 3 studies
Supranuclear Palsy, Progressive: A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vilas, D | 1 |
Sharp, M | 1 |
Gelpi, E | 1 |
Genís, D | 1 |
Marder, KS | 1 |
Cortes, E | 1 |
Vonsattel, JP | 1 |
Tolosa, E | 1 |
Alcalay, RN | 1 |
Choumert, A | 1 |
Poisson, A | 1 |
Honnorat, J | 2 |
Le Ber, I | 1 |
Camuzat, A | 1 |
Broussolle, E | 1 |
Thobois, S | 2 |
Ros, R | 1 |
Streichenberger, N | 1 |
Kopp, N | 1 |
Sánchez, MP | 1 |
Pérez, M | 1 |
Hoenicka, J | 1 |
Avila, J | 1 |
de Yébenes, JG | 1 |
3 other studies available for glycine and Supranuclear Palsy, Progressive
Article | Year |
---|---|
Clinical and neuropathological features of progressive supranuclear palsy in Leucine rich repeat kinase (LRRK2) G2019S mutation carriers.
Topics: Aged; Astrocytes; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Locus Coer | 2018 |
G303V tau mutation presenting with progressive supranuclear palsy-like features.
Topics: Adult; DNA Mutational Analysis; Exons; Family Health; Glycine; Humans; Middle Aged; Supranuclear Pal | 2012 |
A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy.
Topics: Amino Acid Substitution; Blotting, Northern; Blotting, Western; Brain; Dihydroxyphenylalanine; DNA M | 2005 |